Purchase Order HT001416P0143
- Not listed
- This federal contract award to Roche Diagnostics Corporation is for the provision of reagents and consumables. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a ceiling value of $2,250,426.75. The award was made by the Defense Health Agency (DHA), a defense agency, with a period of performance ending on October 5, 2016. This contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro...
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and peripheral supplies. The contract was awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and has a potential value of $2,238,187.65. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
- This federal contract award is a Blanket Purchase Agreement (BPA) against the Department of Veterans Affairs (VA) Schedule #V797P-7347A for reagents and consumables. The contract has a ceiling value of $346,018.42 and was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics and associated products and services. The contract is a Firm Fixed Price arrangement and provides the Defense Health Agency (DHA) with the ability to purchase critical care...
- This contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of REAGENTS AND SUPPLIES, with a Ceiling Value of $98,494.08. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2020. This award is associated with a larger...
- The Defense Health Agency awarded Roche Diagnostics Corporation a $804,117 blanket purchase agreement call contract to provide reagents and peripherals for laboratory testing. The firm fixed price contract was awarded under the agency's indefinite delivery/indefinite quantity diagnostic and laboratory equipment and supplies contract vehicle. Roche will deliver the requested products to support laboratory operations at facilities located in Bethesda, Maryland over an 11-month period of...
- This is a firm fixed-price BPA call order awarded to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, by the Defense Health Agency (DHA). The $15,314.77 contract is for the delivery of reagents with a completion date of September 30, 2023. Roche Diagnostics has held various indefinite delivery contracts and blanket purchase agreements with federal agencies such as the Department of Veterans Affairs, Department of Defense, and Department...
- This is a firm fixed-price BPA call order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and peripheral supplies for the pathology department. The contract, worth $99,999.80, has an ultimate completion date of September 30, 2019. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This award is not set aside and is...
- The Defense Health Agency awarded a $15,965.52 firm fixed-price Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation on July 28, 2025, with completion scheduled for September 30, 2025. This contract, which carries no set-aside designation, procures diagnostic reagents essential for provider and patient management in outpatient care and referral site operations. The government description emphasizes the critical nature of these reagents, noting that failure to acquire them would...
This federal contract award is for the procurement of Roche reagents and consumables by the Defense Health Agency (DHA), a component of the Department of Defense. The contract, identified as HT001416P0143, has a ceiling value of $304,355.00 and was awarded on November 25, 2015 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is a Firm Fixed Price Purchase Order with a period of performance ending on September 30, 2020. The place of performance is Fort Belvoir, Virginia. This award does not appear to have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, through prime contracts and subcontracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $60.9k | 4/7/16 | |
| Not listed | Not listed | $0 | 11/25/15 |